Liposcience Inc (LPDX) Financial Statements (2024 and earlier)

Company Profile

Business Address 2500 SUMNER BOULEVARD
RALEIGH, NC 27616
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2014
MRQ
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 49,574
Cash and cash equivalents 49,574
Receivables 5,821
Inventory, net of allowances, customer advances and progress billings 224
Inventory 224
Other undisclosed current assets 972
Total current assets: 56,591
Noncurrent Assets
Property, plant and equipment 13,955
Intangible assets, net (including goodwill) 841
Intangible assets, net (excluding goodwill) 841
Restricted cash and investments 502
Deferred costs 64
Other noncurrent assets 45
Total noncurrent assets: 15,407
TOTAL ASSETS: 71,998
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 2,045
Accounts payable 2,045
Other undisclosed current liabilities 19,560
Total current liabilities: 21,605
Noncurrent Liabilities
Liabilities, other than long-term debt 2,635
Other liabilities 2,635
Total noncurrent liabilities: 2,635
Total liabilities: 24,240
Equity
Equity, attributable to parent 47,758
Common stock 15
Additional paid in capital 108,271
Accumulated deficit (60,528)
Total equity: 47,758
TOTAL LIABILITIES AND EQUITY: 71,998

Income Statement (P&L) ($ in thousands)

9/30/2014
TTM
12/31/2013
Revenues
(Revenue, Net)
 52,383
Cost of revenue
(Cost of Goods and Services Sold)
 (12,042)
Other undisclosed gross profit 1,300
Gross profit: 41,641
Operating expenses (52,321)
Operating loss: (10,680)
Nonoperating income 87
Investment income, nonoperating 93
Interest and debt expense (1,942)
Loss from continuing operations: (12,535)
Loss before gain (loss) on sale of properties: (12,535)
Net loss available to common stockholders, diluted: (12,535)

Comprehensive Income ($ in thousands)

9/30/2014
TTM
12/31/2013
Net loss: (12,535)
Comprehensive loss, net of tax, attributable to parent: (12,535)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: